학술논문
CLL-115 First Interim Analysis of ALPINE Study: Results of a Phase 3 Randomized Study of Zanubrutinib vs Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Document Type
Article
Author
Brown, Jennifer R. ; Hillmen, Peter ; Eichhorst, Barbara ; Lamanna, Nicole ; O'Brien, Susan ; Tam, Constantine S. ; Qiu, Lugui ; Kazmierczak, Maciej ; Zhou, Keshu ; Šimkovič, Martin ; Mayer, Jiri ; Gillespie-Twardy, Amanda ; Shadman, Mazyar ; Ferrajoli, Alessandra ; Ganly, Peter S. ; Weinkove, Robert ; Salmi, Tommi ; Wu, Kenneth ; Novotny, William ; Jurczak, Wojciech
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S266-S266
Subject
Language
ISSN
2152-2650